HealthSouth Corporation (NYSE:HLS)‘s stock had its “hold” rating reaffirmed by research analysts at Piper Jaffray Companies in a note issued to investors on Sunday. They presently have a $50.00 target price on the stock. Piper Jaffray Companies’ price target would indicate a potential upside of 11.26% from the stock’s current price.

HLS has been the subject of several other research reports. ValuEngine downgraded shares of HealthSouth Corporation from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. Stephens began coverage on shares of HealthSouth Corporation in a research note on Thursday, August 31st. They issued an “overweight” rating and a $53.00 price target for the company. Royal Bank Of Canada restated a “buy” rating and issued a $55.00 price target on shares of HealthSouth Corporation in a research note on Wednesday, September 6th. KeyCorp restated a “hold” rating on shares of HealthSouth Corporation in a research note on Thursday, September 7th. Finally, Zacks Investment Research upgraded shares of HealthSouth Corporation from a “hold” rating to a “buy” rating and set a $55.00 price target for the company in a research note on Thursday, June 29th. Two investment analysts have rated the stock with a sell rating, five have issued a hold rating and three have issued a buy rating to the company’s stock. HealthSouth Corporation presently has a consensus rating of “Hold” and an average price target of $49.71.

HealthSouth Corporation (NYSE:HLS) opened at 44.94 on Friday. The company has a 50 day moving average price of $44.19 and a 200-day moving average price of $44.89. The company has a market cap of $4.44 billion, a PE ratio of 15.82 and a beta of 0.59. HealthSouth Corporation has a 12 month low of $36.97 and a 12 month high of $49.71.

HealthSouth Corporation (NYSE:HLS) last posted its quarterly earnings results on Monday, July 31st. The company reported $0.71 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.68 by $0.03. The business had revenue of $981.30 million during the quarter, compared to the consensus estimate of $976.46 million. HealthSouth Corporation had a net margin of 6.70% and a return on equity of 25.07%. The company’s quarterly revenue was up 6.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.69 earnings per share. Equities analysts predict that HealthSouth Corporation will post $2.71 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This piece was first posted by American Banking News and is the property of of American Banking News. If you are accessing this piece on another website, it was illegally stolen and republished in violation of international trademark & copyright laws. The legal version of this piece can be viewed at https://www.americanbankingnews.com/2017/09/17/healthsouth-corporation-hls-given-hold-rating-at-piper-jaffray-companies.html.

In related news, CEO Mark J. Tarr sold 22,625 shares of the business’s stock in a transaction on Thursday, August 3rd. The shares were sold at an average price of $42.55, for a total transaction of $962,693.75. Following the completion of the transaction, the chief executive officer now owns 283,134 shares in the company, valued at $12,047,351.70. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 1.60% of the company’s stock.

Several hedge funds have recently modified their holdings of HLS. Wellington Management Group LLP grew its stake in shares of HealthSouth Corporation by 4,377.7% during the first quarter. Wellington Management Group LLP now owns 995,082 shares of the company’s stock worth $42,599,000 after purchasing an additional 972,859 shares in the last quarter. Mackay Shields LLC acquired a new position in shares of HealthSouth Corporation during the second quarter worth $39,641,000. TimesSquare Capital Management LLC acquired a new position in shares of HealthSouth Corporation during the second quarter worth $37,868,000. William Blair Investment Management LLC grew its stake in shares of HealthSouth Corporation by 13.9% during the second quarter. William Blair Investment Management LLC now owns 4,302,756 shares of the company’s stock worth $208,253,000 after purchasing an additional 525,767 shares in the last quarter. Finally, Balyasny Asset Management LLC grew its stake in shares of HealthSouth Corporation by 421.4% during the second quarter. Balyasny Asset Management LLC now owns 618,311 shares of the company’s stock worth $29,926,000 after purchasing an additional 499,715 shares in the last quarter. Hedge funds and other institutional investors own 93.10% of the company’s stock.

About HealthSouth Corporation

HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.

Analyst Recommendations for HealthSouth Corporation (NYSE:HLS)

Receive News & Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related companies with MarketBeat.com's FREE daily email newsletter.